Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vericel Corporation
(NQ:
VCEL
)
46.28
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation
< Previous
1
2
3
4
5
Next >
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 03, 2024
From
Vericel Corporation
Via
GlobeNewswire
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.
Via
InvestorPlace
3 Strong Buy Stocks Set to Take Off in the Coming Months
November 10, 2023
These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in?
Via
InvestorPlace
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 08, 2023
From
Vericel Corporation
Via
GlobeNewswire
Analyst Ratings for Vericel
October 16, 2023
Via
Benzinga
Analyst Ratings for Vericel
September 21, 2023
Via
Benzinga
Expert Ratings for Vericel
August 03, 2023
Via
Benzinga
Earnings Scheduled For November 8, 2023
November 08, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via
Benzinga
Vericel to Present at the Stephens Annual Investment Conference
November 07, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Vericel Earnings Perspective: Return On Capital Employed
February 28, 2023
Via
Benzinga
Analyst Expectations for Vericel's Future
February 27, 2023
Via
Benzinga
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 25, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
September 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Analyst Ratings for Vericel
January 27, 2023
Via
Benzinga
Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses
September 20, 2023
J Capital Research has released a short idea report on Vericel Corporation (NASDAQ:
Via
Benzinga
Vericel to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2023
From
Vericel Corporation
Via
GlobeNewswire
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
August 02, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
July 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
May 23, 2023
Via
Investor Brand Network
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
May 10, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
April 26, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
February 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
February 23, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023
February 09, 2023
From
Vericel Corporation
Via
GlobeNewswire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.